SERB Pharmaceuticals is a specialty pharmaceutical company that focuses on the treatment of patients with critical conditions. The company's primary focus is on emergency care and rare diseases. SERB Pharmaceuticals is a combination of SERB, BTG Specialty Pharmaceuticals, and Veriton Pharma, forming a growing specialty pharmaceutical entity. The company also aims to build up management systems that match global practices in the promotion and funding of basic research. They have developed a scheme called SERB-SUPRA for scientific and useful profound research, including drug discovery and the study of chemical toxicity.